Dr. Eric Scott Farbman, MD

Dr. Farbman practices at Community Health Partners in Clovis, California.

Dr. Farbman's NPI, 1912965773, was assigned on May 2, 2006. Dr. Farbman graduated from Rutgers New Jersey Medical School in 1999. Dr. Farbman's South Carolina license number on file is 89127.

Dr. Farbman's primary practice is Community Health Partners, at 789 N Medical Center E Dr, Clovis, CA 93611 in Fresno County. The practice phone is (559) 324-4952.

Dr. Farbman's primary practice is Community Health Partners in Clovis, California. Dr. Farbman is also affiliated with Community Regional Medical Center. The medical group on file is Community Health Partners. Dmand AI also links Dr. Farbman to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farbman practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Farbman's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Farbman is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Farbman's licenses on file in 5 states: South Carolina, California, Nevada, Pennsylvania and Iowa.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, essential tremor, non-alzheimer's dementia (chronic) and parkinson's disease among the conditions Dr. Farbman treats.

CMS data shows 578 Medicare services from Dr. Farbman across 6 procedure codes in 2024, for 358 Medicare patients. Medicare paid $58,132 for them. Every service was in an office.

CMS counts 358 Medicare patients who saw Dr. Farbman in 2024. The largest group is 75 to 84, with 160 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Farbman's median patient age at 68, with 50% women.

In 2024, Dr. Farbman wrote 1,245 Medicare Part D claims for 303 patients. 85% of them were for generic drugs. CMS names the drug for 1,101 of them, across 25 drugs with 11 or more claims each, at $847,015 in total drug cost. In 2023, CMS named 471 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Farbman for performance year 2024, reported as part of a group. Dr. Farbman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Farbman as offering telehealth.

Dmand AI links 6 papers to Dr. Farbman, published from 2016 to 2025. 2016 was the busiest year, with 2. The most frequent topics are Double-Blind Method, Huntington Disease and Outcome Assessment, Health Care. Dr. Farbman has published most often in Parkinsonism Relat Disord. Dr. Farbman's most frequent co-authors are Kelvin Lin-Yu Chou, MD, Andrew Peter Duker, MD and Samuel Arthur Frank, MD.

CMS Open Payments shows 3,035 general payments to Dr. Farbman from 80 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. MDD US Operations, LLC paid the most, $338,787. It also lists 1 research payment totaling $25 in 2018.

Dmand AI lists 2 awards for Dr. Farbman, most recently Vegas Seven in 2014.

Dr. Farbman graduated from Rutgers New Jersey Medical School in 1999. Dr. Farbman is a member of AAN and MDS.

Dr. Farbman is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.